STROKENET REGIONAL COORDINATING CENTER Georgia StrokeNet
STROKENET 区域协调中心 佐治亚州 StrokeNet
基本信息
- 批准号:10457481
- 负责人:
- 金额:$ 30.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2023-12-19
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAgreementCaringClinicalClinical ResearchClinical SciencesClinical TrialsClinical Trials NetworkCollaborationsCommunitiesDataDetectionDisciplineDiseaseEarly treatmentEmergency CareEmergency MedicineEnrollmentEvidence based practiceFundingGoalsHospitalsHourIndividualIndustryInfrastructureInstitutesInstitutional Review BoardsInterventionInterviewInvestigationJointsLeadershipLinkMaster of Public HealthMaster of ScienceMedicalMedicineMethodsMissionMulti-Institutional Clinical TrialNational Institute of Neurological Disorders and StrokeNeurologicNeurological emergenciesNeurologyNeurosciences ResearchOutreach ResearchPatientsPediatricsPeer ReviewPersonsPharmacy EthicsProtocols documentationPublic HealthRandomized Clinical TrialsRecording of previous eventsRecoveryRecurrenceRegistriesRehabilitation therapyResearchResearch AssistantResearch PersonnelResearch Subject RecruitmentsResearch SubjectsResearch TrainingResourcesRiskScientistSiteSourceStrokeStroke preventionStrokeNet clinical trialsStrokeNet trialsSystemTranslatingTranslational ResearchUnited States National Institutes of HealthWorkacute strokebasecareerclinical practicedata managementdata sharingdesigneffective therapyevidence baseexperiencefaculty mentorimprovedinnovationinterestmemberneurosurgeryparticipant enrollmentpatient registrypatient screeningpre-clinicalprogramsrecruitscreeningskillsstroke clinical trialsstroke rehabilitationsuccesssynergismtelestroketraining opportunitytreatment trialworking group
项目摘要
The Specific Aims of this proposal are to: : 1) enhance the successful mission of the Georgia StrokeNet by
accelerating recruitment into NIH StrokeNet clinical trials for patients with acute stroke, people at risk
for recurrent stroke and individuals recovering from stroke; 2) develop and propose new and innovative
clinical trials in stroke to be conducted within the NIH StrokeNet; and 3) enhance the training
opportunities for promising young investigators interested in clinical stroke research as a career.
As a currently-funded NIH StrokeNet Regional Coordinating Center (RCC), the Georgia StrokeNet brings an
established infrastructure of highly successful and collaborative investigators and coordinators, with many years
of proven expertise in designing, conducting, and enrolling patients into randomized clinical trials across the
continuum of stroke care, from pre-hospital through rehabilitation. Our RCC has demonstrated the ability to
quickly implement research protocols using master trial agreements and a central IRB, and has brought to the
existing network strong leadership skills, as evidenced by our team members’ active and ongoing participation
in NIH StrokeNet working groups including Co-Chair of the NIH StrokeNet’s Rehabilitation working group and
the only Project Coordinator representation in the Acute Stroke Working Group since implementation. Emory’s
Georgia StrokeNet proposal builds upon our RCC’s track record of 5 years of highly successful participation as
an NIH StrokeNet site, 10 years as a top enroller for the NINDS-sponsored Neurological Treatment Trials
Network (NETT), recent selection as one of only 11 hubs for the NIH-funded SIREN (Strategies to Innovate
EmeRgENcy Care) Clinical Trials Network, and a 25 year history of high enrollment in multiple NIH and industry
sponsored practice changing randomized clinical trials in stroke.
本提案的具体目标是:1)通过以下方式加强格鲁吉亚StrokeNet的成功使命
加速招募急性卒中患者和高危人群进入NIH StrokeNet临床试验
对于复发性中风和中风恢复的个人; 2)开发和提出新的和创新的
在NIH StrokeNet内进行中风临床试验; 3)加强培训
有前途的年轻研究人员有兴趣在临床中风研究作为一个职业的机会。
作为目前资助的NIH StrokeNet区域协调中心(RCC),格鲁吉亚StrokeNet带来了
多年来,建立了非常成功和协作的调查员和协调员的基础设施
在设计、实施和招募患者参加随机临床试验方面,
中风护理的连续性,从院前到康复。我们的RCC已经证明有能力
使用主试验协议和中央IRB快速实施研究方案,并使
现有的网络强大的领导能力,我们的团队成员的积极和持续的参与证明
NIH StrokeNet工作组,包括NIH StrokeNet康复工作组的联合主席,
自实施以来,急性卒中工作组中唯一的项目协调员代表。埃默里的
格鲁吉亚StrokeNet提案建立在我们RCC 5年来非常成功的参与记录之上,
一个NIH StrokeNet网站,10年来一直是NINDS赞助的神经治疗试验的最佳注册者
网络(NETT),最近被选为NIH资助的SIREN(创新战略)仅有的11个中心之一
EmeRgENcy Care)临床试验网络,以及25年来在多个NIH和行业的高招募历史
赞助的实践改变了中风的随机临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL Ross FRANKEL其他文献
MICHAEL Ross FRANKEL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL Ross FRANKEL', 18)}}的其他基金
STROKENET REGIONAL COORDINATING CENTER Georgia StrokeNet
STROKENET 区域协调中心 佐治亚州 StrokeNet
- 批准号:
9767892 - 财政年份:2018
- 资助金额:
$ 30.47万 - 项目类别:
STROKENET REGIONAL COORDINATING CENTER Georgia StrokeNet
STROKENET 区域协调中心 佐治亚州 StrokeNet
- 批准号:
10306028 - 财政年份:2018
- 资助金额:
$ 30.47万 - 项目类别:
NINDS Stroke Trials Network - Regional Coordinating Stroke Centers (U10)
NINDS 中风试验网络 - 区域中风协调中心 (U10)
- 批准号:
8902282 - 财政年份:2013
- 资助金额:
$ 30.47万 - 项目类别:
NINDS Stroke Trials Network - Regional Coordinating Stroke Centers (U10)
NINDS 中风试验网络 - 区域中风协调中心 (U10)
- 批准号:
8662908 - 财政年份:2013
- 资助金额:
$ 30.47万 - 项目类别:
NINDS Stroke Trials Network - Regional Coordinating Stroke Centers (U10)
NINDS 中风试验网络 - 区域中风协调中心 (U10)
- 批准号:
8739565 - 财政年份:2013
- 资助金额:
$ 30.47万 - 项目类别:
Biomarkers of Injury and Outcome in Pro-TECT III (BIO-ProTECT)
Pro-TECT III (BIO-ProTECT) 中损伤和结果的生物标志物
- 批准号:
8650346 - 财政年份:2011
- 资助金额:
$ 30.47万 - 项目类别:
Biomarkers of Injury and Outcome in Pro-TECT III (BIO-ProTECT)
Pro-TECT III (BIO-ProTECT) 中损伤和结果的生物标志物
- 批准号:
8258750 - 财政年份:2011
- 资助金额:
$ 30.47万 - 项目类别:
Biomarkers of Injury and Outcome in Pro-TECT III (BIO-ProTECT)
Pro-TECT III (BIO-ProTECT) 中损伤和结果的生物标志物
- 批准号:
8465294 - 财政年份:2011
- 资助金额:
$ 30.47万 - 项目类别:
Biomarkers of Injury and Outcome in Pro-TECT III (BIO-ProTECT)
Pro-TECT III (BIO-ProTECT) 中损伤和结果的生物标志物
- 批准号:
8868178 - 财政年份:2011
- 资助金额:
$ 30.47万 - 项目类别:
Biomarkers of Injury and Outcome in Pro-TECT III (BIO-ProTECT)
Pro-TECT III (BIO-ProTECT) 中损伤和结果的生物标志物
- 批准号:
8132774 - 财政年份:2011
- 资助金额:
$ 30.47万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 30.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 30.47万 - 项目类别:
Operating Grants